Yasuaki Saijo Selected Research

Sick Building Syndrome

1/2018	[New Scientific Evidence-based Public Health Guidelines and Practical Manual for Prevention of Sick House Syndrome].
2/2012	A longitudinal study of aldehydes and volatile organic compounds associated with subjective symptoms related to sick building syndrome in new dwellings in Japan.
5/2011	[Variations of indoor environment and the prevalence of sick house syndrome over three-year period in detached houses in Sapporo].
5/2009	[Dampness, biological factors and sick house syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuaki Saijo Research Topics

Disease

6	Hypersensitivity (Allergy) 07/2014 - 01/2006
5	Birth Weight (Birth Weights) 01/2019 - 01/2004
4	Sick Building Syndrome 01/2018 - 05/2009
4	Infections 05/2011 - 09/2007
3	Asthma (Bronchial Asthma) 01/2022 - 07/2014
3	Allergic Rhinitis 06/2020 - 04/2012
3	Hypertension (High Blood Pressure) 01/2020 - 01/2006
3	Occupational Stress 08/2017 - 05/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 10/2010
3	Genetic Predisposition to Disease (Genetic Predisposition) 03/2008 - 12/2005
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 11/2006 - 01/2004
2	Hypothermia 09/2021 - 01/2021
2	Myocardial Infarction 11/2019 - 01/2006
2	Albuminuria 10/2018 - 06/2013
2	Cicatrix (Scar) 08/2015 - 06/2015
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 08/2015 - 06/2015
2	Ventricular Tachycardia 08/2015 - 01/2015
2	Conjunctivitis 07/2014 - 04/2012
2	Neoplasms (Cancer) 09/2013 - 07/2008
2	Azoospermia 01/2012 - 08/2011
2	Diabetes Mellitus 07/2011 - 09/2005
2	Chronic Renal Insufficiency 05/2011 - 05/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2011 - 08/2006
2	Atherosclerosis 05/2011 - 05/2009
2	Inflammation (Inflammations) 05/2009 - 07/2007
2	Glucose Intolerance 03/2007 - 01/2006
2	Hypospadias 01/2006 - 01/2005
2	Cryptorchidism (Undescended Testes) 01/2006 - 01/2005
1	Hemorrhage 01/2022
1	Shock 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Respiratory Sounds (Crackle) 01/2022
1	Disseminated Intravascular Coagulation 09/2021
1	Frailty 09/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Cleft Palate (Palate, Cleft) 01/2021
1	Cleft Lip (Harelip) 01/2021
1	Food Hypersensitivity (Food Allergy) 06/2020
1	Stroke (Strokes) 11/2019
1	Premature Birth (Birth, Premature) 01/2019
1	Hypoxia (Hypoxemia) 10/2018
1	Hyperglycemia 10/2018
1	Hypertrophy 10/2018
1	Sertoli Cell-Only Syndrome 09/2018
1	Fatigue 01/2018
1	Headache (Headaches) 01/2018
1	Poisoning 01/2017
1	Hypokalemia 12/2016
1	Fibrosis (Cirrhosis) 03/2016
1	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 01/2016
1	Premature Obstetric Labor (Premature Labor) 01/2016
1	Cardiac Arrhythmias (Arrythmia) 06/2015
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 07/2014

Drug/Important Bio-Agent (IBA)

5	ORALIT (ORS)IBA 01/2022 - 05/2008
3	PotassiumIBA 09/2021 - 01/2021
3	GadoliniumIBA 03/2016 - 06/2015
3	Volatile Organic CompoundsIBA 04/2012 - 05/2009
3	CytokinesIBA 05/2009 - 06/2005
3	EnzymesIBA 03/2008 - 01/2004
2	Immunoglobulin E (IgE)IBA 06/2020 - 01/2012
2	SmokeIBA 11/2019 - 03/2008
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 07/2014 - 05/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 08/2011
2	Glucose (Dextrose)FDA LinkGeneric 07/2011 - 03/2007
2	AdipokinesIBA 05/2011 - 03/2009
2	DioxinsIBA 05/2011 - 01/2006
2	C-Reactive ProteinIBA 05/2009 - 08/2006
2	Interleukin-6 (Interleukin 6)IBA 09/2007 - 07/2007
2	Diethylstilbestrol (Stilbestrol)FDA Link 01/2006 - 01/2005
2	Endocrine DisruptorsIBA 01/2006 - 01/2005
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 06/2005 - 01/2004
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022
1	KeroseneIBA 01/2022
1	Factor VIIa (Activated Factor VII)IBA 01/2022
1	recombinant FVIIa (rFVIIa)FDA Link 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 09/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	N 30IBA 01/2021
1	Uric Acid (Urate)IBA 01/2020
1	SeleniumIBA 01/2019
1	MercuryIBA 01/2019
1	Caffeine (No Doz)FDA LinkGeneric 01/2019
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 10/2018
1	Hemoglobins (Hemoglobin)IBA 10/2018
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 10/2018
1	ReninIBA 10/2018
1	Histones (Histone)IBA 09/2018
1	Biological ProductsIBA 01/2018
1	BromidesIBA 01/2017
1	SteroidsIBA 12/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2016
1	Ritodrine (Yutopar)FDA Link 01/2016
1	Charcoal (Charbon)IBA 01/2016
1	MagnesiumIBA 01/2015

Therapy/Procedure

2	Activities of Daily Living (ADL) 01/2021 - 01/2005
2	Therapeutics 12/2016 - 06/2013
1	Ambulatory Care (Outpatient Care) 01/2022
1	Length of Stay 09/2021
1	Intravenous Administration 01/2015